TRAIL ELISA Kits

Heilmann, Vondung, Borzikowsky, Szymczak, Krüger, Alkatout, Wenners, Bauer, Klapper, Röcken, Maass, von Karstedt, Schem, Trauzold: "Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients." in: Journal of molecular medicine (Berlin, Germany), Vol. 97, Issue 8, pp. 1155-1167, (2020) (PubMed).

Cartland, Harith, Genner, Dang, Cogger, Vellozzi, Di Bartolo, Thomas, Adams, Kavurma: "Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice." in: Scientific reports, Vol. 7, Issue 1, pp. 1898, (2018) (PubMed).

Kuhn, Nieuwenhuijsen, Karthe, Wirtz: "Stretch-induced apoptosis in rat alveolar epithelial cells is mediated by the intrinsic mitochondrial pathway." in: Experimental lung research, Vol. 43, Issue 1, pp. 49-56, (2017) (PubMed).

Audo, Daien, Papon, Lukas, Vittecoq, Hahne, Combe, Morel: "Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort." in: Arthritis research & therapy, Vol. 17, pp. 193, (2015) (PubMed).

Cheng, Liu, Wang, Zhang, Zhao, Zhang, Jiang: "Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia." in: PLoS ONE, Vol. 10, Issue 12, pp. e0144015, (2015) (PubMed).

Ni, Wu, Peterts, Yamamoto, Qing, Nakanishi: "The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 36, pp. 12488-501, (2015) (PubMed).

Tisato, Garrovo, Biffi, Petrera, Voltan, Casciano, Meroni, Agnoletto, Zauli, Secchiero: "Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine model." in: PLoS ONE, Vol. 9, Issue 12, pp. e115387, (2014) (PubMed).

Duan, Gu, Zhu, Sun, Chen, Feng, Song, Xu, He, He: "Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism." in: International journal for parasitology, Vol. 44, Issue 3-4, pp. 217-24, (2014) (PubMed).

Yi, Elson, Mitsuhashi, Jacobs, Hollovary, Budd, Spiro, Triozzi, Borden: "Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects." in: Oncotarget, Vol. 2, Issue 12, pp. 1155-64, (2012) (PubMed).

Sun, Zhang, Lv, Liu, Jin, Zhang, He, Deng, Liu, Li, Li, Zhou, Xie, Xie, Hu, Duan: "Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha)." in: The Journal of biological chemistry, Vol. 286, Issue 18, pp. 15918-28, (2011) (PubMed).